Streetbeat News

Earnings

HBIO

Harvard Bioscience reported Q4 adjusted EPS of $0.04, missing the consensus estimate of $0.05, and sales of $28.15M, missing the estimate of $29.11M. This represents a year-over-year decrease in sales.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:02 pm

SUP

Superior Industries Intl (NYSE:SUP) reported Q4 2023 GAAP EPS of $(0.440), missing the $(0.170) estimate, with sales of $308.600M also missing the $359.567M estimate, a 23.25% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:02 pm

MEI

Methode Electronics (NYSE:MEI) reported a significant miss in its Q3 earnings, with an adjusted EPS of $(0.33), missing the $0.09 estimate by 466.67%. Year-over-year, this represents a 161.11% decrease from an EPS of $0.54. Quarterly sales were $259.50M, missing the $287.80M estimate by 9.83%, and marking a 7.35% decrease from $280.10M in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:01 pm

ABM

ABM Industries has increased its adjusted earnings per share (EPS) forecast for fiscal year 2024 from the previous range of $3.20 - $3.40 to a new range of $3.30 - $3.45, surpassing the estimated $3.3.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:01 pm

CIEN

Ciena (NYSE:CIEN) reported Q1 adjusted EPS of $0.66, surpassing the $0.48 estimate, and sales of $1.04B, exceeding the $1.02B estimate. This represents a 3.13% increase in EPS and a 1.83% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:01 pm

BIG

Big Lots reported Q4 2024 adjusted EPS of $(0.280), missing the $(0.230) estimate, but sales of $1.432B exceeded the $1.426B estimate.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:01 pm

NRP

Natural Resource Partners reported a Q4 operating cash flow of $77.8 million, an increase from $68.9 million year-over-year. The company also reported a free cash flow of $78.4 million for the same period.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:01 pm

ALB

Albemarle (NYSE:ALB), a leading lithium producer, has been analyzed by 17 analysts revealing a mix of bullish to bearish sentiments with a downward trend in the 12-month price target to $146.06 from $163.81. The company faces challenges with a -10.1% revenue decline and below industry standards in net margin, ROE, and ROA, despite a sound debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 12:00 pm

EW

Analysts have provided diverse opinions on Edwards Lifesciences (NYSE:EW) with a recent average 12-month price target of $87.00, reflecting a 10.29% increase from the previous target. The company, known for its medical devices for heart disease, shows strong financial health with a notable revenue growth rate of 13.78%, a high net margin of 24.11%, and an impressive ROE of 5.56%. Analysts' actions range from raising to lowering ratings, indicating varied expectations for EW's future performance.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 12:00 pm

ABM

ABM Industries (ABM) reported Q1 adjusted EPS of $0.86, surpassing the $0.71 estimate, and sales of $2.07B, exceeding the $2.01B estimate. This represents an 8.86% increase in earnings and a 3.90% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 11:59 am